News

The luxury sports-car maker lifted full-year guidance slightly and reported a ramped up deliveries of new models in the second quarter.

Pre-Market Stock Futures: Futures are trading higher this morning after a brutal day across Wall Street on Wednesday. The combination of the Iran war renewing, oil surging higher, and the continued semiconductor stock sell-off and rotation was just the catalyst needed to launch the selling. As expected, the Federal Reserve held interest rates steady. Still, ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Bloom Energy, Dave, Fiverr, Humana, Las Vegas Sands, Lemonade, Procter & Ga

PBF Energy (PBF) delivered earnings and revenue surprises of +53.58% and +37.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

KKR & Co. (KKR) delivered earnings and revenue surprises of +14.79% and +13.47%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Solstice, a cooling technology supplier, reported adjusted EPS of 88 cents. Wall Street was looking for 77 cents.

Teladoc Health (NYSE:TDOC) reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at BetterHelp prompted the company to reduce its full-year revenue outlook. Consolidated

Plus markets are rebounding after a slightly hawkish FOMC, BTC ETFs flip to inflows and MoonPay launches a new AI product + airdrop

Is Chipotle now affordable?

Wall Street keeps reaching for the dot-com playbook every time an AI stock surges, but Fox Business host Charles Payne thinks that reflex is costing investors something far more valuable than peace of mind.

The South Korean tech giant's memory chip division hit all-time highs on AI server demand, while elevated component costs pushed its mobile unit into the red

Ares Capital continues to provide investors with a durable stream of dividend income.

Warsh gave plenty of assurances but hardly any details.

US stock futures pointed to a higher open on Thursday as investors awaited a key inflation report fo

Find insight on BBVA, London Stock Exchange Group and more in the latest Market Talks covering financial services.

European bourses tracked moderately higher midday Thursday as traders weighed the earnings season, s

By Michael Erman July 30 (Reuters) - Bristol Myers Squibb raised its full-year revenue and profit forecast on Thursday after reporting second-quarter results that came in well ahead of Wall Street

Check Point (CHKP) delivered earnings and revenue surprises of +4.08% and -0.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Federal Reserve Chairman Kevin Warsh praised the bond market’s recent rate moves on Wednesday. He may not feel that way now.

Futures pointed higher Thursday as investors also weighed the Fed's decision to hold rates and rising Treasury yields

Yields on 30-year U.S. Treasurys rose further to hit 5.24%, a 19-year high, before paring gains slightly, in a sign of investors' worries about rising inflation and the Fed’s willingness to combat it. The Fed's statement yesterday delivered “a hawkish hold,” wrote economists at Barclays. “But this was unwound by a dovish presser in which Kevin Warsh emphasized tightening in financial conditions that now seems inconsistent with his reluctance to react to data.”

Ares Management’s biggest private-credit fund took more losses from software loans in the second quarter. The $29 billion Ares Capital Corp. fund swung to a $188 million quarterly unrealized loss from existing loans compared with the same period in 2025, but the result was an improvement from a $306 million loss in the first quarter. While net new loan commitments declined by $323 million in the quarter, the fund did more new deals in June and July, especially with larger companies, fund executives said.

Coinbase reports Q2 earnings after the close on July 30, with Wall Street expecting a soft quarter. Consensus revenue sits near $1.31 billion, down roughly 13% year over year. The EPS consensus has slipped to about $0.15, while HC Wainwright projects $0.05. The bigger question is whether management can justify ...

Xcel (XEL) delivered earnings and revenue surprises of +17.72% and -13.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bristol Myers Squibb faces declining revenue in its legacy drug portfolio, but new products like Opdivo are offsetting the drop.

Investors are weighing up a batch of Big Tech earnings reports, which could help power a market rebound.

Wall Street futures pointed higher pre-bell Thursday after tech colossus Microsoft (MSFT) reported s

Cigna (CI) delivered earnings and revenue surprises of +2.64% and +0.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bristol Myers Squibb raised its outlook for the year after notching higher profit and revenue in the latest quarter, boosted by its portfolio of newer treatments.

Qualcomm shares fell about 5% in premarket trading on Thursday after the chipmaker's warning about higher memory costs ‌and a steeper decline in Apple revenue raised concerns about near-term ‌profit growth. A surge in AI infrastructure spending has tightened semiconductor supply chains, driving up costs ​for memory, wafers, packaging and testing. Qualcomm plans to pass on those increases to customers through double-digit price hikes.

Sensata Technologies (NYSE:ST) reported second-quarter 2026 results that exceeded its expectations, with revenue, adjusted operating income and adjusted earnings per share all rising from a year earlier. Chief Executive Officer Stephan von Schuckmann said the company recorded its fourth consecutive